Accuray Incorporated (ARAY)
USD 1.79
(-6.28%)
USD 1.79
(-6.28%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 142.92 Million USD | -7.17% |
| 2023 | 153.96 Million USD | -3.75% |
| 2022 | 159.95 Million USD | 0.28% |
| 2021 | 159.5 Million USD | 6.43% |
| 2020 | 149.87 Million USD | -7.86% |
| 2019 | 162.65 Million USD | 0.59% |
| 2018 | 161.69 Million USD | 14.4% |
| 2017 | 141.34 Million USD | -10.95% |
| 2016 | 158.71 Million USD | 9.15% |
| 2015 | 145.4 Million USD | 1.82% |
| 2014 | 142.8 Million USD | 46.25% |
| 2013 | 97.64 Million USD | -28.87% |
| 2012 | 137.27 Million USD | 28.0% |
| 2011 | 107.24 Million USD | 3.1% |
| 2010 | 104.01 Million USD | -9.78% |
| 2009 | 115.29 Million USD | 7.8% |
| 2008 | 106.95 Million USD | 33.62% |
| 2007 | 80.03 Million USD | 215.05% |
| 2006 | 25.4 Million USD | 125.58% |
| 2005 | 11.26 Million USD | -42.45% |
| 2004 | 19.56 Million USD | 6273.19% |
| 2003 | -317 Thousand USD | -101.64% |
| 2002 | 19.35 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 38.45 Million USD | 32.26% |
| 2024 FY | 142.92 Million USD | -7.17% |
| 2024 Q1 | 39.49 Million USD | 4.82% |
| 2024 Q2 | 35.9 Million USD | -9.09% |
| 2024 Q3 | 29.07 Million USD | -19.02% |
| 2023 Q1 | 34.59 Million USD | -19.58% |
| 2023 Q4 | 37.67 Million USD | -2.69% |
| 2023 Q3 | 38.71 Million USD | -9.89% |
| 2023 Q2 | 42.96 Million USD | 24.19% |
| 2023 FY | 153.96 Million USD | -3.75% |
| 2022 Q4 | 43.02 Million USD | 23.68% |
| 2022 Q3 | 34.78 Million USD | -18.4% |
| 2022 FY | 159.95 Million USD | 0.28% |
| 2022 Q1 | 39.52 Million USD | -9.62% |
| 2022 Q2 | 42.62 Million USD | 7.85% |
| 2021 Q4 | 43.73 Million USD | 10.59% |
| 2021 Q1 | 35.4 Million USD | -11.26% |
| 2021 FY | 159.5 Million USD | 6.43% |
| 2021 Q2 | 40.83 Million USD | 15.33% |
| 2021 Q3 | 39.54 Million USD | -3.16% |
| 2020 Q1 | 32.94 Million USD | -28.27% |
| 2020 Q2 | 37.9 Million USD | 15.05% |
| 2020 Q3 | 39.13 Million USD | 3.25% |
| 2020 Q4 | 39.89 Million USD | 1.95% |
| 2020 FY | 149.87 Million USD | -7.86% |
| 2019 Q4 | 45.92 Million USD | 13.49% |
| 2019 FY | 162.65 Million USD | 0.59% |
| 2019 Q1 | 37.87 Million USD | -21.06% |
| 2019 Q2 | 38.38 Million USD | 1.32% |
| 2019 Q3 | 40.46 Million USD | 5.44% |
| 2018 Q1 | 38.1 Million USD | -11.76% |
| 2018 Q2 | 39.35 Million USD | 3.28% |
| 2018 FY | 161.69 Million USD | 14.4% |
| 2018 Q3 | 36.24 Million USD | -7.89% |
| 2018 Q4 | 47.98 Million USD | 32.38% |
| 2017 FY | 141.34 Million USD | -10.95% |
| 2017 Q4 | 43.18 Million USD | 21.91% |
| 2017 Q3 | 35.42 Million USD | 12.87% |
| 2017 Q1 | 31.34 Million USD | -15.97% |
| 2017 Q2 | 31.38 Million USD | 0.14% |
| 2016 Q2 | 42.57 Million USD | 25.59% |
| 2016 Q1 | 33.89 Million USD | -16.2% |
| 2016 Q3 | 44.94 Million USD | 5.57% |
| 2016 Q4 | 37.3 Million USD | -17.01% |
| 2016 FY | 158.71 Million USD | 9.15% |
| 2015 Q2 | 38.48 Million USD | 38.44% |
| 2015 FY | 145.4 Million USD | 1.82% |
| 2015 Q4 | 40.45 Million USD | 4.64% |
| 2015 Q3 | 38.66 Million USD | 0.44% |
| 2015 Q1 | 27.8 Million USD | -27.69% |
| 2014 Q3 | 39.7 Million USD | 4.02% |
| 2014 Q1 | 26.47 Million USD | -2.96% |
| 2014 Q2 | 38.17 Million USD | 44.16% |
| 2014 Q4 | 38.44 Million USD | -3.17% |
| 2014 FY | 142.8 Million USD | 46.25% |
| 2013 Q4 | 27.28 Million USD | 36.06% |
| 2013 Q1 | 23.67 Million USD | -35.12% |
| 2013 Q3 | 20.05 Million USD | -24.69% |
| 2013 Q2 | 26.62 Million USD | 12.46% |
| 2013 FY | 97.64 Million USD | -28.87% |
| 2012 FY | 137.27 Million USD | 28.0% |
| 2012 Q4 | 36.49 Million USD | 1.05% |
| 2012 Q1 | 24.42 Million USD | -24.2% |
| 2012 Q2 | 40.24 Million USD | 64.74% |
| 2012 Q3 | 36.11 Million USD | -10.27% |
| 2011 Q4 | 32.22 Million USD | 17.99% |
| 2011 Q3 | 27.31 Million USD | -7.31% |
| 2011 Q2 | 29.46 Million USD | 61.57% |
| 2011 Q1 | 18.23 Million USD | -41.28% |
| 2011 FY | 107.24 Million USD | 3.1% |
| 2010 Q4 | 31.05 Million USD | 22.39% |
| 2010 Q3 | 25.37 Million USD | -2.26% |
| 2010 Q2 | 25.96 Million USD | 20.1% |
| 2010 Q1 | 21.61 Million USD | -20.2% |
| 2010 FY | 104.01 Million USD | -9.78% |
| 2009 Q4 | 27.09 Million USD | -10.78% |
| 2009 Q2 | 29.4 Million USD | 3.45% |
| 2009 Q1 | 28.42 Million USD | 5.7% |
| 2009 FY | 115.29 Million USD | 7.8% |
| 2009 Q3 | 30.36 Million USD | 3.24% |
| 2008 Q4 | 26.89 Million USD | 2.33% |
| 2008 Q2 | 27.86 Million USD | 7.53% |
| 2008 FY | 106.95 Million USD | 33.62% |
| 2008 Q1 | 25.91 Million USD | 3.99% |
| 2008 Q3 | 26.28 Million USD | -5.67% |
| 2007 FY | 80.03 Million USD | 215.05% |
| 2007 Q1 | 19.3 Million USD | 18.12% |
| 2007 Q2 | 14.7 Million USD | -23.84% |
| 2007 Q3 | 21.11 Million USD | 43.64% |
| 2007 Q4 | 24.91 Million USD | 17.98% |
| 2006 Q3 | 16.34 Million USD | 0.0% |
| 2006 Q1 | 3.87 Million USD | -30.8% |
| 2006 FY | 25.4 Million USD | 125.58% |
| 2006 Q2 | 16.34 Million USD | 322.16% |
| 2006 Q4 | 16.34 Million USD | 0.0% |
| 2005 Q1 | 5.59 Million USD | 0.0% |
| 2005 Q3 | 5.59 Million USD | 0.0% |
| 2005 Q2 | 5.59 Million USD | 0.0% |
| 2005 Q4 | 5.59 Million USD | 0.0% |
| 2005 FY | 11.26 Million USD | -42.45% |
| 2004 FY | 19.56 Million USD | 6273.19% |
| 2003 FY | -317 Thousand USD | -101.64% |
| 2002 FY | 19.35 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Envoy Medical, Inc. | -473 Thousand USD | 30315.856% |
| Delcath Systems, Inc. | 1.43 Million USD | -9894.476% |
| Xylo Technologies Ltd. | 11.84 Million USD | -1107.001% |